Skip to content

Agios Pharmaceuticals

US · AGIO #2841 by market cap Listed 1970
31.79 +0.07 +0.22%
Live - 5344 symbols - heartbeat 101s ago · 2026-10-07 19:54
After-hours 31.79 0.00%
Market cap
1.90B
P/B
1.85
EPS
-7.12
Reader sentiment Are you bullish or bearish on AGIO?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Goldman Sachs Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Raises Target Price to $32
    Market Newswire · 2026/6/2
  • Rating change
    BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $46
    Market Newswire · 2026/7/7
  • Rating change
    A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $36 to $54
    Market Newswire · 2026/6/16
  • Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
    Market Newswire · 2026/8/11
  • Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39
    Market Newswire · 2026/7/31
  • Rating change
    H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $54
    Market Newswire · 2026/7/13
  • Rating change
    A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $41 to $54
    Market Newswire · 2026/7/8
  • Rating change
    BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/6/12
  • A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $39 to $55
    Market Newswire · 2026/7/31
  • Rating change
    H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/6/2
  • Rating change
    BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/7/22
  • Rating change
    H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Cuts Target Price to $52
    Market Newswire · 2026/7/22
  • Rating change
    H.C. Wainwright Remains a Buy on Agios Pharma (AGIO)
    TipRanks · 2026/7/13
  • Rating change
    J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Maintains Target Price $31
    Market Newswire · 2026/6/11
  • BofA Securities Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/9/21
  • Company notice
    Agios Pharmaceuticals: Agios Pharmaceuticals, Inc. - Flex Position Consolidation Option Symbol: 1AGIO
    OCC · 2022/4/28
  • Rating change
    J.P. Morgan Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating, Announces Target Price $31
    Market Newswire · 2026/6/11
  • TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
    Market Newswire · 2026/8/4
  • Rating change
    Truist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $36
    Market Newswire · 2026/6/15
  • Rating change
    H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Raises Target Price to $54
    Market Newswire · 2026/6/15

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.